2-巯基乙基硬脂酸酯 | 27564-01-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 2-巯基乙基硬脂酸酯
• 中文别名: 2-巯基乙基硬脂酸盐
• 英文名称: 2-Mercaptoethyl stearate
• 英文别名: 2-sulfanylethyl octadecanoate
• CAS: 27564-01-8
• 化学式: C₂₀H₄₀O₂S
• 分子量: 344.6
• InChiKey: FPRWILGFWFTOHA-UHFFFAOYSA-N

物化性质

• 沸点：
  428.9±28.0 °C(Predicted)
• 密度：
  0.916±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  8.8
• 重原子数：
  23
• 可旋转键数：
  19
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.95
• 拓扑面积：
  27.3
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• High purity monoalkyltin compounds and uses thereof
  申请人：ARKEMA FRANCE

  公开号：EP2123659A1

  公开（公告）日：2009-11-25

  The present invention relates to high purity monoalkyltin compounds, more specifically to alkyltin compound compositions containing monoalkyltin as major compound, and minor quantities of di- and/or trialkyltin compounds. The present invention also relates to the preparation processes of such high purity monoalkyltin compounds, as well as to the uses of said monoalkyltin compounds as chlorine-containing polymer-stabilisers, glass coating chemicals and catalysts, as well as articles comprising at least one polymer matrix and a high purity monoalkyltin compound.

  本发明涉及高纯度的单烷基锡化合物，更具体地是含有单烷基锡作为主要化合物的烷基锡化合物组合物，以及少量的二烷基锡和/或三烷基锡化合物。本发明还涉及制备这种高纯度单烷基锡化合物的过程，以及将所述单烷基锡化合物用作含氯聚合物稳定剂、玻璃涂层化学品和催化剂的用途，以及包含至少一个聚合物基质和高纯度单烷基锡化合物的制品。
• 2' ,5' -Oligoadenylate analogs
  申请人：Koizumi Makoto

  公开号：US20050261235A1

  公开（公告）日：2005-11-24

  A 2-5A analog represented by the formula (1): wherein m is 0 or 1; n is 0 to 2; R 1 represents an alkoxy group having from 1 to 6 carbon atoms which may be substituted, an unprotected mercapto group, a mercapto group protected by a nucleic acid synthesis protecting group, or an alkylthio group having from 1 to 4 carbon atoms which may be substituted; R 2 , R 3 , R 4 , R 5 and R 6 represent an unprotected hydroxyl group, a hydroxyl group protected by a nucleic acid synthesis protecting group, an alkoxy group having from 1 to 6 carbon atoms which may be substituted, an unprotected mercapto group, a mercapto group protected by a nucleic acid synthesis protecting group, or an alkylthio group having from 1 to 4 carbon atoms which may be substituted; R 7 represents an oxygen atom, or a —O(CH 2 CH 2 O)q-group, wherein q is 2 to 6; R 8 represents a hydrogen atom, an alkyl group having from 1 to 6 carbon atoms which may be substituted, or a 5′-phosphorylated oligonucleotide analog which has one hydroxyl group removed from the 5′-phosphoric acid group; E 1 , E 2 , E 3 and E 4 represent a naturally occurring or modified nucleic acid unit, or a pharmacologically acceptable salt thereof.

  一种由公式（1）表示的2-5A模拟物，其中m为0或1；n为0至2；R1表示具有1至6个碳原子的烷氧基，可以被取代，未保护的巯基，通过核酸合成保护基保护的巯基，或者具有1至4个碳原子的烷硫基，可以被取代；R2、R3、R4、R5和R6表示未保护的羟基，通过核酸合成保护基保护的羟基，具有1至6个碳原子的烷氧基，可以被取代，未保护的巯基，通过核酸合成保护基保护的巯基，或者具有1至4个碳原子的烷硫基，可以被取代；R7表示氧原子，或者-O(CH2CH2O)q-基团，其中q为2至6；R8表示氢原子，具有1至6个碳原子的烷基，可以被取代，或者从5'-磷酸基团中去除一个羟基的5'-磷酸寡核苷酸类似物；E1、E2、E3和E4表示天然或修饰的核酸单元，或其药理学上可接受的盐。
• Monosubstituted 6-aminouracils for the stabilization of halogenated polymers
  申请人：Wehner Wofgang

  公开号：US20060148941A1

  公开（公告）日：2006-07-06

  Compositions comprising a chlorinated polymer and at least one compound of formula (I) where R 1 or R 2 =linear or branched C 3 -C 22 alkyl, unsubstituted or substituted with C 1 -C 4 alkyl/alkoxy and/or hydroxy phenyl, unsubstituted or substituted by C 1 -C 4 alkyl/alkoxy and/or hydroxy phenyl C 1 -C 4 alkyl, linear or branched C 3 -C 18 alkenyl, C 3 -C 8 — cycloalkyl, C 3 -C 10 alkyl or C 3 -C 10 hydroxyalkyl or acetoxy/benzoyloxy C 2 -C 10 alkyl interrupted by at least one oxygen atom, as stabilisers for halogenated polymers.

  含有氯化聚合物和至少一种化合物（I）的组合物，其中R1或R2=线性或支链C3-C22烷基，未取代或取代C1-C4烷基/烷氧基和/或羟基苯基，未取代或取代C1-C4烷基/烷氧基和/或羟基苯基C1-C4烷基，线性或支链C3-C18烯基，C3-C8环烷基，C3-C10烷基或C3-C10羟基烷基或至少一个氧原子中断的乙酰氧基/苯甲酰氧基C2-C10烷基，作为卤代聚合物的稳定剂。
• Method of treating a tumor or a viral disease by administering a 2' , 5' -oligoadenylate analog
  申请人：Koizumi Makoto

  公开号：US20100035976A1

  公开（公告）日：2010-02-11

  A method of treating a tumor or a viral disease by administering to a human the following 2′,5′-oligoadenylate analog: Wherein m is 0; n is 0 or 1; R 1 is alkoxy substituted by hydroxyl, mercapto, alkylthio substituted by hydroxyl or X 1 —X 2 —X 3 —S—; R 2 , R 3 , R 4 , R 5 and R 6 are hydroxyl, mercapto, alkylthio substituted by hydroxyl or X 1 —X 2 —X 3 —S—; R 7 is oxygen, sulfur, —NH—, or —O(CH 2 CH 2 O)q-, wherein q is 2 to 6, or oxyalkyleneoxy; R 8 is hydrogen or a 5′-phosphorylated oligonucleotide which has one hydroxyl removed from the 5′-phosphoric acid; E 1 is K 2 ; E 2 is K 1 ; E 3 is K 2 or K 3 and E 4 is K 1 , K 2 or K 3 ; K 1 is K 2 is K 3 is B is adeninyl; A is alkylene; D is alkyl or alkenyl; X 1 is alkyl or phenyl; X 2 is —C(═O)O—, —OC(═O)— or —C(═O)S—; and X 3 is alkylene.

  一种通过向人体内注射以下2′，5′-寡腺苷酸类似物来治疗肿瘤或病毒性疾病的方法：其中m为0；n为0或1；R1为烷氧基，被羟基，巯基，被羟基的烷基硫代基或X1—X2—X3—S—取代的烷氧基；R2，R3，R4，R5和R6为羟基，巯基，被羟基的烷基硫代基或X1—X2—X3—S—；R7为氧，硫，—NH—，或—O(CH2CH2O)q-，其中q为2至6，或氧烷氧基；R8为氢或一个5′-磷酸寡核苷酸，其5′-磷酸上有一个羟基被去除；E1为K2；E2为K1；E3为K2或K3，E4为K1，K2或K3；K1，K2和K3为B为腺苷基；A为烷基；D为烷基或烯基；X1为烷基或苯基；X2为—C(═O)O—，—OC(═O)—或—C(═O)S—；X3为烷基。
• Coordination-polymeric triethanolamineperchlorato(triflato)metal inner complexes as additives for synthetic polymers
  申请人：Wehner Wolfgang

  公开号：US20090105387A1

  公开（公告）日：2009-04-23

  Stabilizer system for chlorinated polymers, especially PVC, comprising at least one coordination-polymeric triethanolamineperchlorato(triflato)metal inner complex comprising the monomer unit of the formula (A) The stabilizer system may additionally comprise substituted cyanoacetylureas or/and 6-aminouracils or/and 3-aminocrotonic esters or/and hydantoins or/and monomeric or polymeric dihydropyridines or alkaline earth metal hydroxides or/and hydrotalcites or/and dawsonites or/and zeolites or/and glycidyl compounds or/and cyanamides or/and cyanoguanidines or/and melamines. In addition, phosphites or/and sterically hindered amines or/and NOR-HALS compounds may be present.

  氯化聚合物的稳定剂体系，特别是PVC，包括至少一种配位聚合三乙醇胺高氯酸盐（三氟乙酸盐）金属内部络合物，该络合物包括式（A）的单体单位。稳定剂系统还可以包括取代的氰乙酰脲或/和6-氨基尿嘧啶或/和3-氨基巴豆酸酯或/和恒化酮或/和单体或聚合二氢吡啶或碱土金属氢氧化物或/和水滑石或/和道森石或/和沸石或/和环氧丙烷化合物或/和氰胺或/和氰基脲或/和三聚氰胺。此外，磷酸酯或/和立体阻隔胺或/和NOR-HALS化合物也可能存在。